{"disease":{"id":"radiation","name":"radiation"},"drugs":{"marketed":[{"drug_id":"osimertinib","indication_name":"Treatment of adult patients with locally advanced, unresectable (stage III) NSCLC whose disease has not progressed during or following concurrent or sequential platinum-based chemoradiation therapy and whose tumors have EGFR exon 19 deletions or exon 21 L858R mutations","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tagrisso","generic_name":"osimertinib","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"ALK tyrosine kinase receptor","drug_class":"Kinase Inhibitor [EPC]","quality_score":67,"revenue":"5800","mechanism":"Osimertinib is a kinase inhibitor of the epidermal growth factor receptor (EGFR) that binds irreversibly to mutant forms of EGFR."},{"drug_id":"somatropin-adult-cohort","indication_name":"Treatment of growth hormone deficiency in adults with a history of radiation therapy to the head.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"somatropin - adult cohort","generic_name":"somatropin-adult-cohort","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Growth Hormone Receptor","drug_class":"Growth Hormone","quality_score":10,"revenue":"446","mechanism":""},{"drug_id":"loteprednol-etabonate-and-tobramycin","indication_name":"Corneal injury from chemical, radiation, or thermal burns","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"loteprednol etabonate and tobramycin","company_name":"Bausch & Lomb Incorporated","drug_phase":"marketed","molecular_target":"","drug_class":"Aminoglycoside Antibacterial [EPC]","quality_score":31,"revenue":null,"mechanism":null},{"drug_id":"lysine","indication_name":"Renal radiation exposure from Lutetium (177Lu) oxodotreotide","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"L-Lysine","generic_name":"LYSINE","company_name":"Advanced Accelerator Applications","drug_phase":"marketed","molecular_target":"Glutathione reductase, mitochondrial","drug_class":"lysine","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"pentetate-calcium-trisodium","indication_name":"Exposure to Americium Radiation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pentetate Calcium Trisodium","generic_name":"PENTETATE CALCIUM TRISODIUM","company_name":"Hameln","drug_phase":"marketed","molecular_target":"","drug_class":"pentetate calcium trisodium","quality_score":10,"revenue":null,"mechanism":"Pentetate Calcium Trisodium works by binding to radioactive ions, such as Americium, Curium, and Plutonium, to facilitate their excretion from the body."},{"drug_id":"pentetate-calcium-trisodium","indication_name":"Exposure to Curium Radiation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pentetate Calcium Trisodium","generic_name":"PENTETATE CALCIUM TRISODIUM","company_name":"Hameln","drug_phase":"marketed","molecular_target":"","drug_class":"pentetate calcium trisodium","quality_score":10,"revenue":null,"mechanism":"Pentetate Calcium Trisodium works by binding to radioactive ions, such as Americium, Curium, and Plutonium, to facilitate their excretion from the body."},{"drug_id":"pentetate-calcium-trisodium","indication_name":"Exposure to Plutonium Radiation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pentetate Calcium Trisodium","generic_name":"PENTETATE CALCIUM TRISODIUM","company_name":"Hameln","drug_phase":"marketed","molecular_target":"","drug_class":"pentetate calcium trisodium","quality_score":10,"revenue":null,"mechanism":"Pentetate Calcium Trisodium works by binding to radioactive ions, such as Americium, Curium, and Plutonium, to facilitate their excretion from the body."},{"drug_id":"potassium-iodide","indication_name":"Thyroid Gland Radiation Protection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Potassium Iodide","generic_name":"POTASSIUM IODIDE","company_name":"Roxane","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 4","drug_class":"","quality_score":23,"revenue":null,"mechanism":null},{"drug_id":"irinotecan-carboplatin-erbitux","indication_name":"First-line treatment of patients with squamous cell carcinoma of the head and neck (SCCHN) in combination with 5-fluorouracil and radiation therapy.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"irinotecan + Carboplatin + erbitux","generic_name":"irinotecan-carboplatin-erbitux","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"topoisomerase I, platinum DNA damage, epidermal growth factor receptor","drug_class":"chemotherapy","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"estrone","indication_name":"Prevention of Radiation-Induced Nausea and Vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Estron","generic_name":"ESTRONE","company_name":"Watson Labs","drug_phase":"marketed","molecular_target":"Estrogen receptor","drug_class":"estrone","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"gran","indication_name":"Prevention of Radiation-Induced Nausea and Vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"GRAN®","company_name":"EVIVE Biotechnology","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3B, Multidrug and toxin extrusion protein 1, Solute carrier family 22 member 2","drug_class":"","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"hydroxyurea","indication_name":"Locally advanced squamous cell carcinomas of the head and neck (excluding lip) in combination with concurrent chemoradiation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"HYDROXYUREA","company_name":"","drug_phase":"marketed","molecular_target":"Ribonucleotide reductase","drug_class":"Antimetabolite [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"arginine","indication_name":"Renal radiation exposure from Lutetium (177Lu) oxodotreotide","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"R-Gene 10","generic_name":"ARGININE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Nitric oxide synthase, inducible","drug_class":"arginine hydrochloride","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"pilocarpine","indication_name":"Xerostomia Secondary to Radiation Therapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Salagen","generic_name":"PILOCARPINE","company_name":"","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M4","drug_class":"Cholinergic Receptor Agonist","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"amifostine","indication_name":"Prevention of Xerostomia Secondary to Radiation Therapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ethyol","generic_name":"AMIFOSTINE","company_name":"Cosette","drug_phase":"marketed","molecular_target":"D(3) dopamine receptor","drug_class":"amifostine","quality_score":75,"revenue":null,"mechanism":"Ethyol works by protecting the kidneys and salivary glands from damage caused by chemotherapy and radiation."},{"drug_id":"palifermin","indication_name":"Mucositis following radiation therapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Kepivance","generic_name":"PALIFERMIN","company_name":"Biovitrum Ab","drug_phase":"marketed","molecular_target":"Fibroblast growth factor receptor 2","drug_class":"Mucocutaneous Epithelial Cell Growth Factor [EPC]","quality_score":60,"revenue":null,"mechanism":"Kepivance works by binding to fibroblast growth factor receptor 2, stimulating the growth and proliferation of mucosal cells."},{"drug_id":"palifermin","indication_name":"Prevention of Radiation Therapy-Induced Mucositis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Kepivance","generic_name":"PALIFERMIN","company_name":"Biovitrum Ab","drug_phase":"marketed","molecular_target":"Fibroblast growth factor receptor 2","drug_class":"Mucocutaneous Epithelial Cell Growth Factor [EPC]","quality_score":60,"revenue":null,"mechanism":"Kepivance works by binding to fibroblast growth factor receptor 2, stimulating the growth and proliferation of mucosal cells."},{"drug_id":"salagen","indication_name":"Xerostomia Secondary to Radiation Therapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Salagen","company_name":"Alberta Health services","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"pegfilgrastim-pbbk","indication_name":"Increase survival in radiation exposure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"FYLNETRA","generic_name":"PEGFILGRASTIM-PBBK","company_name":"KASHIV BIOSCIENCES LLC","drug_phase":"marketed","molecular_target":"specific cell surface receptors","drug_class":"Leukocyte Growth Factor [EPC]","quality_score":10,"revenue":null,"mechanism":"Pegfilgrastim binds to specific cell surface receptors on hematopoietic cells, stimulating their proliferation, differentiation, and functional activation."},{"drug_id":"ondansetron","indication_name":"Prevention of Radiation-Induced Nausea and Vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zofran","generic_name":"ondansetron","company_name":"GSK (originally Glaxo)","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, 5-hydroxytryptamine receptor 3B, Multidrug and toxin extrusion protein 1","drug_class":"5-HT3 receptor antagonist (antiemetic)","quality_score":null,"revenue":null,"mechanism":"Selective 5-HT3 receptor antagonist that blocks serotonin-mediated nausea and vomiting signals in the CTZ and vagal afferents."},{"drug_id":"filgrastim-txid","indication_name":"Radiation Exposure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"NYPOZI","generic_name":"FILGRASTIM-TXID","company_name":"TANVEX BIOPHARMA USA INC","drug_phase":"marketed","molecular_target":"Specific cell surface receptors on hematopoietic cells","drug_class":"Leukocyte Growth Factor [EPC]","quality_score":50,"revenue":null,"mechanism":"G-CSF binds to specific receptors on hematopoietic cells, stimulating neutrophil production and function."}],"pipeline":[],"offLabel":[],"totalMarketed":21,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03776435","title":"CT Carcinogenic Risk in Patients With Appendicitis","phase":"","overall_status":"UNKNOWN","enrollment_count":1000000,"lead_sponsor_name":"Seoul National University Bundang Hospital","has_results":false},{"nct_id":"NCT05380570","title":"Epidemiological Study of Korean Radiation Workers","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":196379,"lead_sponsor_name":"Korea Institute of Radiological & Medical Sciences","has_results":false},{"nct_id":"NCT00410475","title":"Cancer Risk in X-Ray Technologists: Second Survey","phase":"","overall_status":"COMPLETED","enrollment_count":146022,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT07054528","title":"Multicentre Real-life Data Collection Study With CareMin650™ in the Prevention and Treatment of Oral Mucositis and Radio- and/or Chemo-induced Dermatitis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":33000,"lead_sponsor_name":"Centre Hospitalier de Valenciennes","has_results":false},{"nct_id":"NCT06565793","title":"A MAajor RAdiation-based PCI Study in STEMI and NSTEMI","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":15630,"lead_sponsor_name":"Centre Cardiologique du Nord","has_results":false},{"nct_id":"NCT03649451","title":"Reference Dose Levels During Fluoroscopically Guided Procedures in Operating Rooms","phase":"","overall_status":"COMPLETED","enrollment_count":8840,"lead_sponsor_name":"Societe Francaise de Physique Medicale","has_results":false},{"nct_id":"NCT04075305","title":"The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study","phase":"","overall_status":"RECRUITING","enrollment_count":8000,"lead_sponsor_name":"UMC Utrecht","has_results":false},{"nct_id":"NCT00769223","title":"Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3561,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT05135208","title":"Optimized Camera-based Patient Positioning in CT","phase":"","overall_status":"COMPLETED","enrollment_count":3118,"lead_sponsor_name":"Dr. Panagiota Manava","has_results":false},{"nct_id":"NCT05203250","title":"Longitudinal Registry Including Patients Treated With Heavy Particles","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"CNAO National Center of Oncological Hadrontherapy","has_results":false},{"nct_id":"NCT06531681","title":"Precision Radiotherapy for Tumours Using Magnetic Resonance-guided Linear Accelerator (MR-Linac)","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"The Second Affiliated Hospital of Hainan Medical University","has_results":false},{"nct_id":"NCT03461341","title":"European iNvestigation of SUrveillance After Resection for Esophageal Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":3000,"lead_sponsor_name":"St. James's Hospital, Ireland","has_results":false},{"nct_id":"NCT03298204","title":"Definitive (Chemo)Radiotherapy for Patients With Esophageal Cancer - 3JECROG R-01","phase":"","overall_status":"COMPLETED","enrollment_count":2762,"lead_sponsor_name":"Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT07199101","title":"Multicenter Pediatric Low-Dose CT Protocol: Development and Clinical Verification","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":2650,"lead_sponsor_name":"Beijing Children's Hospital","has_results":false},{"nct_id":"NCT04821843","title":"Neoadjuvant Treatment Modalities in Esophageal Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT04821778","title":"Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT07426094","title":"PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":1600,"lead_sponsor_name":"Affidea Nu-med Center of Oncological DIagnostics and Therapy","has_results":false},{"nct_id":"NCT03607578","title":"Test of Interventions to Prevent Skin Cancer Among Danes on Vacation in High UV Index Sunny Destinations","phase":"NA","overall_status":"COMPLETED","enrollment_count":1548,"lead_sponsor_name":"Brian Køster","has_results":false},{"nct_id":"NCT04291378","title":"The DBCG Proton Trial: Photon Versus Proton Radiation Therapy for Early Breast Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":1502,"lead_sponsor_name":"Danish Breast Cancer Cooperative Group","has_results":false},{"nct_id":"NCT06356779","title":"Longitudinal Study of Local Ablative Therapy in Oligometastatic Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Gitte Fredberg Persson MD PhD","has_results":false},{"nct_id":"NCT07343349","title":"Addition of Focal Boost to Primary Radiotherapy for Prostate Cancer in 12 or 20 Fractions","phase":"NA","overall_status":"RECRUITING","enrollment_count":1016,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT05702060","title":"Randomized Comparison of Radiation Exposure to Operators in Coronary Intervention Between Right Radial and Left DRA","phase":"NA","overall_status":"COMPLETED","enrollment_count":1010,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT04285944","title":"Operator Radiation Protection During Cardiac Catheterization Using Mavig X-ray Protective Drapes®.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT01407770","title":"Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":false},{"nct_id":"NCT06233578","title":"ATTENUATE (rAdpad proTecTion drapE iN redUcing rAdiaTion Exposure) Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"NYU Langone Health","has_results":true},{"nct_id":"NCT04403815","title":"Radiation Exposure During Coronary Procedures According to Vascular Access","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Azienda ULSS 3 Serenissima","has_results":false},{"nct_id":"NCT06556979","title":"Carotid Artery Stenosis and Ischemic Cerebrovascular Events After Radiotherapy in Patients With Head and Neck Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":907,"lead_sponsor_name":"Chulabhorn Royal Academy","has_results":false},{"nct_id":"NCT06384105","title":"Study of the Patient Radiation Dose During Five Endourological Procedures","phase":"NA","overall_status":"RECRUITING","enrollment_count":870,"lead_sponsor_name":"Universiteit Antwerpen","has_results":false},{"nct_id":"NCT07008716","title":"Omitting CTV for Primary Tumor in LS-SCLC","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":852,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06111430","title":"Long-term Neurovascular Complications After Radiation Therapy in Head and Neck Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT03139968","title":"Reduction of Catheterization Radiation Exposure Pad","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":766,"lead_sponsor_name":"J.P.S Henriques","has_results":false},{"nct_id":"NCT04528225","title":"A Prospective Study of Hypothyroidism After Radiotherapy for Breast Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":729,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT06308328","title":"A Real-world Observational Study of a Mucosal Contouring Method for Radiation-induced Oropharyngeal Mucositis","phase":"","overall_status":"RECRUITING","enrollment_count":718,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT05858385","title":"Predictive Study on Acute Radiation Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients","phase":"","overall_status":"RECRUITING","enrollment_count":700,"lead_sponsor_name":"Affiliated Cancer Hospital & Institute of Guangzhou Medical University","has_results":false},{"nct_id":"NCT03538782","title":"Patients Radiation Exposure in Percutaneous Transhepatic Biliary Drainage (PTBD) Procedures","phase":"","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"Theresienkrankenhaus und St. Hedwig-Klinik GmbH","has_results":false},{"nct_id":"NCT05844982","title":"Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Jaeb Center for Health Research","has_results":false},{"nct_id":"NCT04110223","title":"Validation Studies of Biomarkers for Precision Radiation Oncology in Locally Advanced Solid Tumors","phase":"","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Shandong Cancer Hospital and Institute","has_results":false},{"nct_id":"NCT06536699","title":"Trial Comparing Avg. Global Qual of Lifescore in Hypo Frac. RT vs Conv. Frac. in H&N Cancers","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Tata Medical Center","has_results":false},{"nct_id":"NCT05566613","title":"Prediction of Individual Radiosensitivity During Radiotherapy for Breast Cancer Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":550,"lead_sponsor_name":"Karolinska University Hospital","has_results":false},{"nct_id":"NCT04069884","title":"RecurIndex Guided Avoidance of Regional Nodal Irradiation for Node Positive Breast Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":540,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT03071289","title":"A Trial Comparing Observation With Radiation on Pelvic Lymphocysts After Radical Hysterectomy of Cervical Cancer","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":540,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT03734952","title":"Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma With Neoadjuvant Chemoradiotherapy","phase":"NA","overall_status":"RECRUITING","enrollment_count":537,"lead_sponsor_name":"Fujian Medical University Union Hospital","has_results":false},{"nct_id":"NCT05833516","title":"Hyper Adduction of Right Radial Artery/Arm vs Left Drag Over Technique","phase":"","overall_status":"COMPLETED","enrollment_count":534,"lead_sponsor_name":"Maimonides Medical Center","has_results":false},{"nct_id":"NCT06931171","title":"Zero-cost Radiation Protection Method to Reduce Radiation Exposure of Interventional Cardiologists During Transradial Percutaneous Coronary Procedures (FREEPADRAD Trial)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":500,"lead_sponsor_name":"National and Kapodistrian University of Athens","has_results":false},{"nct_id":"NCT06826885","title":"Safety and Efficacy of IMPT or IMRT for Breast Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT06950073","title":"Curatively Intended Thoracic Reirradiation","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT04389190","title":"Radiation Dose Reduction Using Advanced Fluoroscopy Options in Coronary Cath Lab","phase":"NA","overall_status":"UNKNOWN","enrollment_count":480,"lead_sponsor_name":"Tabba Heart Institute","has_results":false},{"nct_id":"NCT03471741","title":"Intensity Modulated Radiotherapy With Concomitant Boost in Breast Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":451,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT03461224","title":"Modulated Accelerated RAdiotherapy in Early Breast Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":447,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT06546592","title":"Locally Optimised Contouring With AI Technology for Radiotherapy","phase":"NA","overall_status":"RECRUITING","enrollment_count":444,"lead_sponsor_name":"Royal North Shore Hospital","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}